<code id='E408B798EB'></code><style id='E408B798EB'></style>
    • <acronym id='E408B798EB'></acronym>
      <center id='E408B798EB'><center id='E408B798EB'><tfoot id='E408B798EB'></tfoot></center><abbr id='E408B798EB'><dir id='E408B798EB'><tfoot id='E408B798EB'></tfoot><noframes id='E408B798EB'>

    • <optgroup id='E408B798EB'><strike id='E408B798EB'><sup id='E408B798EB'></sup></strike><code id='E408B798EB'></code></optgroup>
        1. <b id='E408B798EB'><label id='E408B798EB'><select id='E408B798EB'><dt id='E408B798EB'><span id='E408B798EB'></span></dt></select></label></b><u id='E408B798EB'></u>
          <i id='E408B798EB'><strike id='E408B798EB'><tt id='E408B798EB'><pre id='E408B798EB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:664
          Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT
          Adobe

          In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

          “One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

          advertisement

          Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Roche to buy Carmot Therapeutics, developer of obesity drugs
          Roche to buy Carmot Therapeutics, developer of obesity drugs

          SebastienBozon/AFPviaGettyImagesLONDON—Theboomingobesitymarketisattractinganotherplayer,aspharmagian

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Dog Aging Project founders on what lies ahead after losing funding

          CelebratingabirthdayatHappyBarkDay,thefirstdogcafeintheGulfemirateofDubai.KARIMSAHIB/AFPviaGettyImag